AO Santa Maria Degli Angeli

Creation of a telemedicine system for the oncological paediatrics ward. 

ASL Lanusei

Tele-monitoring of chronic patients who suffer from COPD to preventively intervene in relapses.

ASL Rieti

Home Tele-monitoring for the potentiation of the integrated home assistance service, which is provided at local level.

IRCCS di Messina Istituto Neurolesi Bonino Pulejo

Creation of a telemedicine and tele-assistance system for patients who suffer from rare diseases.

Province of Catania

Creation, test and launch of a video-assistance net for disadvantaged people in the area of the Etna coast.

ULSS 12 Veneziana and ULSS 14 in Chioggia

Creation of a telemedicine system, particularly focused on patients who suffer from heart failure.

AOU in Cagliari and Associazione InvitaLaVita

Home tele-monitoring of heart patients and patients who suffer from bronchopathy in the framework of the LEO (Life E-health Observation) project.

Policlinico Universitario Campus Biomedico di Roma

Home tele-monitoring for chronic patients who suffer from heart failure and COPD to early identify ominous signs of re-intensification of the pathology.

AUSL Valle d’Aosta

Regional Tele-Assistance for patients with chronic pathologies. PHEBO® helps carrying out tele-monitoring and assistance activities in the patients’ house, in nursing homes or in micro-communities.  

AO Legnano

Home tele-monitoring for chronic patients who suffer from heart failure. PHEBO® enables to measure several biometric data (blood pressure, blood oxygen level, heart rate, ECG), which are sent to the Control Room for them to be monitored.

ASL Foligno

PHEBO® helps healthcare operators in their monitoring activities during integrated home assistance. The project intends to implement the eVoNurse module and link it to the pulse oximeter, the sphygmomanometer, the scale and the ECG 12 derivations.

Ospedale Pediatrico Bambino Gesù in Rome

Telemedicine service for patients who suffer from Idiopathic Nephrotic Syndrome. PHEBO® allows to control patients who are subject to the experimental protocol for the introduction of a new drug. This project involves: Ospedale Sant’Orsola (BO), Azienda Ospedaliera (PD), Fondazione Ca’ Granda (MI), Ospedale Santobono (NA), Ospedale Gaslini (GE), Ospedale Pediatrico Meyer (FI), Ospedale G. Di Cristina (PA), Ospedale Pediatrico G. Salesi (AN), Ospedale Pediatrico Giovanni XXIII (BA), Ospedale S’Anna (TO), Istituto per l’Infanzia B. Garofano (TS).

This website and third party tools uses some cookies necessary to make some functions available.

Closing this banner or proceeding in the navigation of the website you agree to use our cookies.